Citation Impact
Citing Papers
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Promoter Choice Determines Splice Site Selection in Protocadherin α and γ Pre-mRNA Splicing
2002 StandoutNobel
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
2013
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas
2010
Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues
2007
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in North African Jews with phenylketonuria
1993
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Early prognostic factors for intellectual outcome in CHARGE syndrome
2003
Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease
1998
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
2017
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a
2008
Cytotoxicity of bilirubin for human fibroblasts and rat astrocytes in culture. Effect of the ratio of bilirubin to serum albumin
1996
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Hepatocellular adenoma: Classification, variants and clinical relevance
2016
Genetics of pulmonary hypertension: from bench to bedside
2002
Biochemical and molecular aspects of genetic disorders of bilirubin metabolism
1998
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Clinical classification of pulmonary hypertension
2004 Standout
Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
2018
Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old
2007
Hyperbilirubinemia results in reduced oxidative injury in neonatal gunn rats exposed to hyperoxia
1995
Angiogenesis in health and disease
2003 Standout
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias
1997
Genetic variants in pre-eclampsia: a meta-analysis
2013
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old
2012
Estudio de la eficacia y utilidad de la fisioterapia respiratoria en la bronquiolitis aguda del lactante hospitalizado. Ensayo clínico aleatorizado y doble ciego
2012
CHARGE syndrome: an update
2007
Drug delivery systems for RNA therapeutics
2022
Food intake during the previous 24 h as a percentage of usual intake: a marker of hypoxia in infants with bronchiolitis: an observational, prospective, multicenter study
2013
Human UDP‐glucuronosyl transferases: Chemical defence, jaundice and gene therapy
1993
Bladder cancer
2016 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
2005
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
1999
Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.
1994
Pre-eclampsia
2010 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Sickle-cell disease
2010 Standout
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
2015
Genetic diseases of bilirubin metabolism: the inherited unconjugated hyperbilirubinemias
1996
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Microarray Analysis and Organization of Circadian Gene Expression in Drosophila
2001 StandoutNobel
Development of cerebellar hypoplasia in jaundiced Gunn rats: a quantitative light microscopic analysis
1997
The role of SOX10 during enteric nervous system development
2013
World distribution of factor V Leiden
1995 Standout
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
2015
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
1998 Standout
Neonatal Hyperbilirubinemia
2001 Standout
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Why are some genetic diseases common?
1993
Genes and the preeclampsia syndrome
2008
Pre-eclampsia
2015 Standout
Hepatocellular carcinoma
2022 Standout
CHD7 cooperates with PBAF to control multipotent neural crest formation
2010 StandoutNature
Pulmonary Complications of Sickle Cell Disease
2012
Hepatocellular Carcinoma
2019 Standout
Geometric and Electronic Structure/Function Correlations in Non-Heme Iron Enzymes
1999 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Racial variability in the UDP-glucuronosyltransferase 1 ( UGT1A1 ) promoter: A balanced polymorphism for regulation of bilirubin metabolism?
1998 Standout
Early prognostic factors for intellectual outcome in CHARGE syndrome
2003
Pulmonary Arterial Hypertension
2006
Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease
2010
Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis
1997
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier
2012 StandoutNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Haploinsufficiency of t e lomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita
2005 StandoutNobel
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Evaluation of an Alternative Chest Physiotherapy Method in Infants With Respiratory Syncytial Virus Bronchiolitis
2011
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chest physiotherapy using passive expiratory techniques does not reduce bronchiolitis severity: a randomised controlled trial
2011
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Works of Philippe Labrune being referenced
Bilirubin Uridine Diphosphate Glucuronosyltransferase Hepatic Activity in Jaundice Associated with Congenital Hypothyroidism
1992
Spectrum of phenylketonuria mutations in Western Europe and North Africa, and their relation to polymorphic DNA haplotypes at the phenylalanine hydroxylase locus
1991
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis
2002
IS A POLYMORPHISM OF THE APOLIPOPROTEIN E GENE ASSOCIATED WITH PREECLAMPSIA?
2002
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation
2011
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
2012
Alu-mediated deletion of SOX10 regulatory elements in Waardenburg syndrome type 4
2012
Effectiveness of Chest Physiotherapy in Infants Hospitalized with Acute Bronchiolitis: A Multicenter, Randomized, Controlled Trial
2010
CHARGE syndrome: Report of 47 cases and review
1998
Genetic heterogeneitiy of Crigler-Najjar syndrome type I: A study of 14 cases
1994
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)
2002
Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency
1999
Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I)
2002
Current Therapy for Crigler–Najjar Syndrome Type 1: Report of A World Registry
1996
Inter‐observer agreement between physicians, nurses, and respiratory therapists for respiratory clinical evaluation in bronchiolitis
2009
Gunn rats: a reproducible experimental model to compare the different methods of measurements of bilirubin serum concentration and to evaluate the risk of bilirubin encephalopathy
1990
Hepatocellular Adenomas in Glycogen Storage Disease Type I and III: A Series of 43 Patients and Review of the Literature
1997
Place actuelle de la kinésithérapie respiratoire dans la prise en charge de la bronchiolite aiguë du nourrisson hospitalisé
2011
Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome
2019
Guidelines for management of glycogen storage disease type I—European study on glycogen storage disease type I (ESGSD I)
2002
Cerebellar Symptoms as the Presenting Manifestations of Bilirubin Encephalopathy in Children with Crigler-Najjar Type I Disease
1992
Crigler‐Najjar type II disease inheritance: A family study
1989
The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28
1994
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I)
2002